A Phase 2 interventional study of Oral Bonoprazan and Oral Esomeprazol in Gastrointestinal Erosions and/or Ulcers, sponsored by Shinshu University. Recruiting at 1 site in Japan. Open to participants aged 20 Years to 99 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-09-21.
Sponsored by Shinshu University · Phase 2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The aim of this study is to collect the data of clinical efficacy and safety after the usage of bonoprazon and esomeprazole when the patients take NSAIDs more than 2 weeks and have gastrointestinal symptoms who have had gastrointestinal erosions and/or ulcers in the past.
359 studies on the registry are indexed under Ulcer; 60 are open to participants now.
This study's planned enrollment of 124 is above the median of 65 across 291 interventional studies indexed under Ulcer.
Browse Ulcer studies →Shinshu University is the lead sponsor of 16 studies on the registry; 9 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Daily intake of Bonoprazan
Drug: Oral Bonoprazan
Daily intake of Esomeprazol
Drug: Oral Esomeprazol
To examine the efficacy of oral Bonoprazan in patients with NSAIDs-induced Erosions and/or Ulcers
To examine the efficacy of oral Esomeprazol in patients with NSAIDs-induced Erosions and/or Ulcers
Number of participants with healing of gastrointestinal erosions and/or ulcers using major forceps
Time frame: Change from Baseline Gastrointestinal erosions and/or ulcers at 2 weeks
Started Nov 2017 (actual). Primary completion is estimated for Nov 2022, 60 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Esomeprazole
Shinshu University